Listen "Adjuvant ATR Inhibition Prolonged Life in Patients with Relapsed Small Cell Lung Cancer"
Episode Synopsis
Dr. Takahashi talks with OncTimes Talk’s Peter Goodwin about the Phase 2 study he presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 11 - 15, 2023. Dr. Takahashi reported an improvement in median overall survival among patients with relapsed small cell lung cancer who had the ATR inhibitor berzosertib added to standard topotecan.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.